Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp gained 0.660% compared to yesterday.
Our community is currently low on Integra LifeSciences Holdings Corp with 1 Buy predictions and 5 Sell predictions.
A slightly negative potential of -8.5% at a current price of 7.65 € for Integra LifeSciences Holdings Corp is the result of a target price of 7 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 0.660% | -3.165% | -25.000% | -62.864% | -27.830% | -84.700% | -86.216% |
| Haemonetics Corp. | -0.950% | -0.952% | 6.557% | - | -24.088% | - | - |
| Bio-Rad Labs Inc. A | 2.330% | 0.086% | 1.169% | 0.129% | -9.422% | -46.981% | -51.333% |
| Neogen Corp. | -3.730% | -4.908% | -17.112% | -8.824% | 26.016% | - | - |
Comments
Integra LifeSciences (IART) had its price target lowered by Citigroup Inc. from $11.00 to $9.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat